JW Lifescience Corporation
234080.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
167
Cost of Revenue
124
Gross Profit
43
Gross Margin
25.8%
Operating Income
27
Operating Margin
16.1%
Net Income
33
Net Margin
19.8%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
58
EBITDA Margin
34.5%
2023
12/31/2023
Revenue
155
Cost of Revenue
116
Gross Profit
39
Gross Margin
25.3%
Operating Income
24
Operating Margin
15.5%
Net Income
21
Net Margin
13.6%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
38
EBITDA Margin
24.6%
2022
12/31/2022
Revenue
142
Cost of Revenue
106
Gross Profit
36
Gross Margin
25.5%
Operating Income
20
Operating Margin
14.3%
Net Income
11
Net Margin
7.9%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
33
EBITDA Margin
23.1%
2021
12/31/2021
Revenue
127
Cost of Revenue
90
Gross Profit
37
Gross Margin
28.9%
Operating Income
21
Operating Margin
16.7%
Net Income
10
Net Margin
7.6%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
28
EBITDA Margin
22.1%
2020
12/31/2020
Revenue
138
Cost of Revenue
93
Gross Profit
45
Gross Margin
32.4%
Operating Income
30
Operating Margin
21.5%
Net Income
13
Net Margin
9.4%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
28
EBITDA Margin
20.5%